
Eric Dein ejdein1
4 years 5 months ago
Sustained remission is rare, should we settle for sustained low disease activity? Abst#0480 ESPOIR Cohort says no, get remission if possible for better radiographic (Sharp) and fxnal (HAQ) scores. Maybe perfect isn't enemy of good? @RheumNow. #ACR20 https://t.co/QNQn9n27rm


Richard Conway RichardPAConway
4 years 5 months ago
Dr Alba reports that in GCA angiotensin II system appears to be activated. Losartan reversed changes and reduced inflammatory markers. Possible role in GCA treatment? @rheumnow #ACR20 Abstr#510 https://t.co/IPp3lD1BUH


Janet Pope Janetbirdope
4 years 5 months ago
Early RA pts may develop chronic widespread pain. Not all have fibromyalgia. Multiple areas of pain & inflammation ^ chronic pain & other factors ie women high initial pain longer symptoms @CRASCRRheum @RheumNow #ACR20 abstr#187 1/3 at onset have regional pain 1/4 at 1yr https://t.co/7qOxH4h7Dd https://t.co/IFO1uwyR0o


Richard Conway RichardPAConway
4 years 5 months ago
Dr Ferrada and colleagues assess relapsing polychondritis cohort for VEXAS. Prevalence of 8%. Male sex or age at onset >50 + MCV >100 + platelet count< 200 classified between VEXAS and RP with 100% sens and 96% spec @rheumnow @petercgrayson #ACR20 Abstr#509 #ACRbest https://t.co/5QMu4Y6xSH


Mrinalini Dey DrMiniDey
4 years 5 months ago
Highlighting results from @rheum_covid at #ACR20
Race/ethnicity Associated with Poor Outcomes in #RheumaticDisease Patients with #COVID19 by @MilenaGianfran et al
Abstract #0006👉https://t.co/13jsl8BjcH
Full paper👉https://t.co/Qeo0dOoIOQ
@RheumNow
https://t.co/U9cgaYYaOj

Bella Mehta bella_mehta
4 years 5 months ago
#ACR20 keynote Infectious disease Dr Eric Rubin @NEJM EIC answers questions about medications, immunity and vaccines in #COVID19. Many post covid inflammatory symptoms but not sure if its because of background autoimmunity. Need more data. More to come in a few months @RheumNow

Bella Mehta bella_mehta
4 years 5 months ago
#ACR20 Basic Science Year-in-review Really important work by @danaorange showing PRIME cells can predict flares in #RheumatoidArthritis patients #HSSrheum @RheumNow
https://t.co/XTqqinAN2a https://t.co/24HkqgHS0H


HSS Physician-in-Chief HSS_PIC
4 years 5 months ago
Proud of #HSSRheum! Check out the full list of our 76 Abstracts and 27 moderator and speaker sessions at #ACR20 Convergence here: https://t.co/OoQSzoRxGq. Special congratulations to our two awardees - Roberta Horton and Dr. Jane Salmon! https://t.co/cDkzgFtEH3


Bella Mehta bella_mehta
4 years 5 months ago
Emerging trend #MachineLearning - SpA expert Dr Dennis Poddubnyy talks at #ACR20 press conference - Development and Validation of an #artificial_intelligence Approach for the Detection of Radiographic Sacroiliitis using MRI @RheumNow

Bella Mehta bella_mehta
4 years 5 months ago
#ACR20 year in review by @JYazdanyMD latest data PEXIVAS and SEMIRA trials on corticosteroids - would you change your clinical practice to minimize even low dose Corticosteroids in RA and Vasculitis? @RheumNow
https://t.co/l7PTyANpjq
https://t.co/MRGbsjaGae

Eric Dein ejdein1
4 years 5 months ago
Ready for #ACR20 with an obstructed view. @RheumNow https://t.co/oFVc90DpEM


Eric Dein ejdein1
4 years 5 months ago
ACR president Dr. Ellen Gravallese: "We should be in the room where it happens" because "our knowledge and insights are highly relevant" #ACR20 @RheumNow #Hamilton

Eric Dein ejdein1
4 years 5 months ago
"Educational conferences will never be the same" Ellen Gravallese, MD. Already in action at #ACR20 @RheumNow

Eric Dein ejdein1
4 years 5 months ago
Eric Rubin, MD, editor-in-chief @NEJM #ACR20 discusses how New Zealand can have large rugby matches by intervening before infection occurs. #LTF, @RheumNow.

Eric Dein ejdein1
4 years 5 months ago
Eric Rubin, MD, editor-in-chief @NEJM: "All of the vaccines are based on the same hypothesis". Scary thought in relying in one solution #ACR20. @RheumNow